Typicality: | 0.313 |
Saliency: | 0.149 |
in infants | 14 | other |
currently | 7 | temporal |
therapy → be evaluated in → a phase 1/2 multicenter trial | 7 |
negative | neutral | positive |
0.017 | 0.952 | 0.031 |
Raw frequency | 7 |
Normalized frequency | 0.149 |
Modifier score | 0.500 |
Perplexity | 22.244 |